These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15008033)

  • 1. Adherence to oral therapy for type 2 diabetes: opportunities for enhancing glycemic control.
    Bartels D
    J Am Acad Nurse Pract; 2004 Jan; 16(1):8-16. PubMed ID: 15008033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data.
    McAdam-Marx C; Bellows BK; Unni S; Wygant G; Mukherjee J; Ye X; Brixner DI
    J Manag Care Spec Pharm; 2014 Jul; 20(7):691-700. PubMed ID: 24967522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to select and combine oral agents for patients with type 2 diabetes mellitus.
    Chipkin SR
    Am J Med; 2005 May; 118 Suppl 5A():4S-13S. PubMed ID: 15850548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving oral pharmacologic treatment and management of type 2 diabetes.
    Dailey GE
    Manag Care; 2004 Feb; 13(2):41-7. PubMed ID: 15004930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The power of two: an update on fixed-dose combinations for type 2 diabetes.
    Harris SB
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1453-1462. PubMed ID: 27498671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of insulin to oral therapy in patients with type 2 diabetes.
    Nelson SE; Palumbo PJ
    Am J Med Sci; 2006 May; 331(5):257-63. PubMed ID: 16702795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A
    Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns and obstacles to oral antidiabetic medications adherence among type 2 diabetics in Ismailia, Egypt: a cross section study.
    Heissam K; Abuamer Z; El-Dahshan N
    Pan Afr Med J; 2015; 20():177. PubMed ID: 26113919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes.
    Tan E; Yang W; Pang B; Dai M; Loh FE; Hogan P
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1195-202. PubMed ID: 26679968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
    Oladapo AO; Barner JC; Rascati KL; Strassels SA
    Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of basal insulin to oral antidiabetic agents: a goal-directed approach to type 2 diabetes therapy.
    Kuritzky L
    MedGenMed; 2006 Nov; 8(4):34. PubMed ID: 17415316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
    Kardas P
    Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report.
    Koro CE; Bowlin SJ; Bourgeois N; Fedder DO
    Diabetes Care; 2004 Jan; 27(1):17-20. PubMed ID: 14693960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study.
    Balkrishnan R; Rajagopalan R; Camacho FT; Huston SA; Murray FT; Anderson RT
    Clin Ther; 2003 Nov; 25(11):2958-71. PubMed ID: 14693318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens.
    Vittorino Gaddi A; Benedetto D; Capello F; Di Pietro C; Cinconze E; Rossi E; De Sando V; Cevenini M; D'Alò G
    Public Health; 2014 Jan; 128(1):70-6. PubMed ID: 23969148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy with oral antidiabetic drugs].
    Kautzky-Willer A; Lechleitner M; Pieber TR; Prager R; Roden M; Wascher TC; Weitgasser R
    Acta Med Austriaca; 2004; 31(5):162-3. PubMed ID: 15747987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.
    Willey CJ; Andrade SE; Cohen J; Fuller JC; Gurwitz JH
    Am J Manag Care; 2006 Aug; 12(8):435-40. PubMed ID: 16886886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.